This crisis is a serious threat to scientific progress. Dubious results fuel skepticism of mainstream medicine, legitimizing radicals like RFK, Jr. who claim academic publishing is corrupt to its coreโmerely a vehicle for boosting Big Pharma’s profits. Addressing the problem requires systemic changes: punishing bad behavior in the academy, promoting open data sharing, enforcing rigorous peer review and incentivizing replication studies. Journals and funding agencies must prioritize negative results, and institutions should reward transparency over sensationalism.
Without these reforms, the scientific methodโs foundationโreliable, verifiable evidenceโcould crumble, slowing progress and risking additional harmful policies or applications. By fostering a culture of integrity, science can regain credibility and advance more efficiently, ensuring discoveries are robust and trustworthy for future generations.
But the question remains: will the science community consistently implement these critical solutions? Join Dr. Liza Lockwood and Cam English on this episode of Facts and Fallacies as they tackle the replication crisis with GLP contributor Dr. Kevin Folta.
Podcast: Play in new window | Download
Subscribe: RSS
Kevinย M. Folta is a professor in the Horticultural Sciences Department at the University of Florida and host of the Talking Biotech podcast. Follow Professor Folta on Twitterย @kevinfolta
Dr. Liza Lockwood is a medical toxicologist and the medical affairs lead at Bayer Crop Science. Follow her on X @DrLizaMD
Cameron J. English is the director of bio-sciences at the American Council on Science and Health. Follow him on X @camjenglish

























